A detailed history of Black Rock Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,272,162 shares of AUPH stock, worth $75.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,272,162
Previous 8,662,978 7.03%
Holding current value
$75.3 Million
Previous $43.4 Million 21.99%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.81 - $5.78 $2.93 Million - $3.52 Million
609,184 Added 7.03%
9,272,162 $52.9 Million
Q1 2024

May 10, 2024

SELL
$4.93 - $9.31 $1.27 Million - $2.4 Million
-258,071 Reduced 2.89%
8,662,978 $43.4 Million
Q4 2023

Feb 13, 2024

BUY
$7.13 - $9.49 $3.63 Million - $4.83 Million
508,652 Added 6.05%
8,921,049 $80.2 Million
Q3 2023

Nov 13, 2023

BUY
$7.77 - $12.27 $616,650 - $973,784
79,363 Added 0.95%
8,412,397 $65.4 Million
Q2 2023

Aug 11, 2023

BUY
$8.96 - $11.69 $3.85 Million - $5.02 Million
429,319 Added 5.43%
8,333,034 $80.7 Million
Q1 2023

May 12, 2023

SELL
$5.94 - $11.27 $1.58 Million - $3.01 Million
-266,803 Reduced 3.27%
7,903,715 $86.6 Million
Q4 2022

Feb 13, 2023

BUY
$4.11 - $8.14 $1.88 Million - $3.72 Million
457,463 Added 5.93%
8,170,518 $35.3 Million
Q3 2022

Nov 14, 2022

SELL
$6.66 - $12.39 $657,262 - $1.22 Million
-98,688 Reduced 1.26%
7,713,055 $58 Million
Q2 2022

Aug 12, 2022

BUY
$8.95 - $12.8 $53.6 Million - $76.6 Million
5,984,327 Added 327.47%
7,811,743 $78.5 Million
Q1 2022

May 12, 2022

BUY
$10.05 - $22.48 $67,103 - $150,098
6,677 Added 0.37%
1,827,416 $22.6 Million
Q4 2021

Feb 10, 2022

BUY
$17.78 - $33.08 $16.3 Million - $30.4 Million
918,076 Added 101.71%
1,820,739 $41.6 Million
Q3 2021

Nov 09, 2021

BUY
$10.93 - $23.55 $3.19 Million - $6.87 Million
291,672 Added 47.74%
902,663 $20 Million
Q2 2021

Aug 11, 2021

BUY
$10.0 - $14.52 $6.11 Million - $8.87 Million
610,991 New
610,991 $7.92 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.